Food-as-medicine execs respond to Kellogg CEO’s ‘let them eat flakes’ remarks

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Food-as-Medicine Execs Are Responding to Kellogg CEO's 'Let Them Eat Flakes' Remarks Kellogg CEO Gary Pilnick recently encouraged families struggling to put food on the table to turn to cereal as their go-to dinner option. Food-as-medicine executives are none too thrilled about his comments — they argue that the remarks underscore the dire need to increase public education about affordable, healthy meal planning. Sponsored Content A Personalized Approach to Medication Nonadherence Presented by MedCity News & Abarca Healt At the Abarca Forward conference earlier last year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.  Learn More. Early Bird Gets the Savings Join us for expert-led panel sessions featuring speakers from Morgan Health, Delta Air Lines, GE HealthCare, Alfie Health, Visana and more. "The conference provides a boutique platform for investors and entrepreneurs to gather, acquire insights, and exchange ideas about progress in the healthtech ecosystem." ~ Dennis Depenbush, President, MHIN and New Ventures, BCBS Kansas. Get Your Early Bird $300 Savings Now

Featured News

The Top Strategies Healthcare Organizations Can Use to Reduce Denials Here are six actionable steps healthcare organizations can take to reduce their likelihood of denials and write-offs. Trends Shaping the Next Generation of Healthcare Workers Healthcare organizations will need to proactively engage the next generation of workers in order to meet demand. They can start by factoring in these trends and creating an environment that supports a healthy work-life balance, finding opportunities to prioritize flexibility, and leaving room to staff up for new and expanding care fields. Report: Few Large Employers Have Changed Abortion Coverage Following Dobbs v. Jackson Only 8% of large employers have reduced or expanded their coverage for abortion after the Dobbs v. Jackson decision, a new report from KFF found. Akero's New MASH Drug Data: Longer Treatment Leads to More Liver Benefit Akero Therapeutics' preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment. The latest Akero data build on six-month results reported in 2022.

Resources

Recent Hires, Layoffs & an Interview with Adam Petrich, Chief Medical Officer at QuantHealth For this episode of the MedCity Moves Podcast, Katie Adams chats with Adam Petrich, who recently became QuantHealth's first chief medical officer. Learn more about Petrich's career journey in the pharmaceutical world and why he made the move to QuantHealth. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe